ARTICLE | Company News
Avalon seeks boost from GE cell therapy manufacturing tech
July 24, 2019 10:23 PM UTC
Avalon partnered with GE Healthcare to use its FlexFactory Cell Therapy platform to standardize, automate and accelerate the production of Avalon's cell therapies, including its lead candidate, a next generation CAR T therapy.
While Avalon GloboCare Corp. (NASDAQ:AVCO) is based in New Jersey, GE's platform will be rolled out first in Avalon's GMP facility in Nanjing...